Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 31 results.
User Information
Export Records
  1. 1.   HNO Protects the Myocardium against Reperfusion Injury, Inhibiting the mPTP Opening via PKCe Activation
  2. Mancardi, Daniele; Pagliaro, Pasquale; Ridnour,Lisa; Tocchetti, Carlo G; Miranda, Katrina; Juhaszova, Magdalena; Sollott, Steven J; Wink,David; Paolocci, Nazareno
  3. Antioxidants (Basel, Switzerland). 2022, Feb 14; 11(2):
  1. 2.   New Therapeutic Opportunities for the Treatment of Squamous Cell Carcinomas: A Focus on Novel Driver Kinases
  2. Bensen, Ryan; Brognard,John
  3. International Journal of Molecular Sciences. 2021, Mar; 22(6):
  1. 3.   Orange is the new black: Kinases are the new master regulators of tumor suppression
  2. An,Elvira; Brognard,John
  3. IUBMB LIFE. 2019, JUN; 71(6): 738-748.
  1. 4.   Protein kinase Ca gain-of-function variant in Alzheimer's disease displays enhanced catalysis by a mechanism that evades down-regulation
  2. Callender, Julia A; Yang, Yimin; Lordén, Gema; Stephenson, Natalie L; Jones, Alexander C; Brognard, John; Newton, Alexandra C
  3. Proceedings of the National Academy of Sciences of the United States of America. 2018, Jun 12; 115(24): E5497-E5505.
  1. 5.   Structural Basis for the Failure of the C1 Domain of Ras Guanine Nucleotide Releasing Protein 2 (RasGRP2) to Bind Phorbol Ester with High Affinity.
  2. Czikora, Agnes; Lundberg, Daniel J; Abramovitz, Adelle; Lewin, Nancy E; Kedei, Noemi; Peach, Megan L; Zhou, Xiaoling; Merritt, Raymond C; Craft, Elizabeth A; Braun, Derek C; Blumberg, Peter M
  3. The Journal of biological chemistry. 2016, May 20; 291(21): 11133-47.
  1. 6.   Protein kinase C regulates ezrin-radixin-moesin phosphorylation in canine osteosarcoma cells
  2. Hong, S. H.; Osborne, T.; Ren, L.; Briggs, J.; Mazcko, C.; Burkett, S. S.; Khanna, C.
  3. Veterinary and Comparative Oncology. 2011, Sep; 9(3): 207-218.
  1. 7.   Protein Kinase C zeta Mediates mu-Opioid Receptor-induced Cross-desensitization of Chemokine Receptor CCR5
  2. Song, C. C.; Rahim, R. T.; Davey, P. C.; Bednar, F.; Bardi, G.; Zhang, L.; Zhang, N.; Oppenheim, J. J.; Rogers, T. J.
  3. Journal of Biological Chemistry. 2011, Jun; 286(23): 20354-20365.
  1. 8.   Membrane anchoring of diacylglycerol lactones substituted with rigid hydrophobic acyl domains correlates with biological activities
  2. Raifman, O.; Kolusheva, S.; Comin, M. J.; Kedei, N.; Lewin, N. E.; Blumberg, P. M.; Marquez, V. E.; Jelinek, R.
  3. Febs Journal. 2010, Jan; 277(1): 233-243.
  1. 9.   Characterization of the interaction of phorbol esters with the C1 domain of MRCK (myotonic dystrophy kinase-related Cdc42 binding kinase) alpha/beta
  2. Choi, S. H.; Czifra, G.; Kedei, N.; Lewin, N. E.; Lazar, J.; Pu, Y. M.; Marquez, V. E.; Blumberg, P. M.
  3. Journal of Biological Chemistry. 2008 283(16): 10543-10549.
  1. 10.   Conformationally constrained analogues of diacylglycerol. 29. Cells sort diacylglycerol-lactone chemical zip codes to produce diverse and selective biological activities
  2. Duan, D.; Sigano, D. M.; Kelley, J. A.; Lai, C. C.; Lewin, N. E.; Kedei, N.; Peach, M. L.; Lee, J.; Abeyweera, T. P.; Rotenberg, S. A.; Kim, H.; Kim, Y. H.; El Kazzouli, S.; Chung, J. U.; Young, H. A.; Young, M. R.; Baker, A.; Colburn, N. H.
  3. Journal of Medicinal Chemistry. 2008 51(17): 5198-5220.
  1. 11.   Effects on ligand interaction and membrane translocation of the positively charged arginine residues situated along the C1 domain binding cleft in the atypical protein kinase C isoforms
  2. Pu, Y. M.; Peach, M. L.; Garfield, S. H.; Wincovitch, S.; Marquez, V. E.; Blumberg, P. M.
  3. Journal of Biological Chemistry. 2006, Nov; 281(44): 33773-33788.
  1. 12.   Actin is the primary cellular receptor of bistramide A
  2. Statsuk, A. V.; Bai, R. L.; Baryza, J. L.; Verma, V. A.; Hamel, E.; Wender, P. A.; Kozmin, S. A.
  3. Nature Chemical Biology. 2005, DEC; 1(7): 383-388.
  1. 13.   Binding of pregnancy-specific glycoprotein 17 to CD9 on macrophages induces secretion of IL-10, IL-6, PGE(2) and TGF-beta(1)
  2. Ha, C. T.; Waterhouse, R.; Wessells, J.; Wu, J. A.; Dveksler, G. S.
  3. Journal of Leukocyte Biology. 2005, JUN; 77(6): 948-957.
  1. 14.   Inositol hexaphosphate (IP6) blocks proliferation of human breast cancer cells through a PKC delta-dependent increase in p27(Kip1) and decrease in retinoblastoma protein (pRb) phosphorylation
  2. Vucenik, I.; Ramakrishna, G.; Tantivejkul, K.; Anderson, L. M.; Ramljak, D.
  3. Breast Cancer Research and Treatment. 2005, MAY; 91(1): 35-45.
  1. 15.   PKC delta plays opposite roles in growth mediated by wild-type Kit and an oncogenic Kit mutant
  2. Jelacic, T.; Linnekin, D.
  3. Blood. 2005, MAR 1; 105(5): 1923-1929.
  1. 16.   Protein kinase C zeta is required for epidermal growth factor-induced chemotaxis of human breast cancer cells
  2. Sun, R. H.; Gao, P.; Chen, L.; Ma, D. L.; Wang, J. M.; Oppenheim, J. J.; Zhang, N.
  3. Cancer Research. 2005, FEB 15; 65(4): 1433-1441.
  1. 17.   Protein kinase C alpha-mediated chemotaxis of neutrophils requires NF-kappa B activity but is independent of TNF alpha signaling in mouse skin in vivo
  2. Cataisson, C.; Pearson, A. J.; Torgerson, S.; Nedospasov, S. A.; Yuspa, S. H.
  3. Journal of Immunology. 2005, FEB 1; 174(3): 1686-1692.
  1. 18.   A proinflarnmatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1
  2. Zhang, N.; Inan, S.; Cowan, A.; Sun, R. H.; Wang, J. M.; Rogers, T. J.; Caterina, M.; Oppenheim, J. J.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2005 102(12): 4536-4541.
  1. 19.   Conformationally constrained analogues of diacylglycerol (DAG). 23. Hydrophobic ligand-protein interactions versus ligand-lipid interactions of DAG-lactones with protein kinase C (PK-C)
  2. Tamamura, H.; Sigano, D. M.; Lewin, N. E.; Peach, M. L.; Nicklaus, M. C.; Blumberg, P. M.; Marquez, V. E.
  3. Journal of Medicinal Chemistry. 2004, SEP 23; 47(20): 4858-4864.
  1. 20.   The discovery of protein kinase C (PK-C) isozyme: Specific ligands driven by a solid-phase combinatorial synthesis of diacylglycerol-lactones (DAG-lactones)
  2. Duan, D. H.; Peach, M. L.; Lai, C. C.; Lewin, N. E.; Kelley, J. A.; Blumberg, P. M.; Marquez, V. E.
  3. Abstracts of Papers of the American Chemical Society. 2004, AUG 22; 228(Part 1): 177-MEDI, Abstract U939-177-MEDI, Abstract U939.
  1. 21.   Hydrophobic ligand-protein interactions vs. ligand-lipid interactions of DAG-lactones with protein kinase C (PK-C)
  2. Sigano, D. M.; Tamamura, H.; Lewin, N. E.; Peach, M. L.; Nicklaus, M. C.; Blumberg, P. M.; Marquez, V. E.
  3. Abstracts of Papers of the American Chemical Society. 2004, AUG 22; 228(Part 1): 229-MEDI, Abstract U949-229-MEDI, Abstract U949.
  1. 22.   New design approaches aimed at targeting atypical PKC isoform zeta with diacylglycerol-lactones (DAG-lactones)
  2. Kang, J. H.; Peach, M. L.; Blumberg, P. M.; Marquez, V. E.
  3. Abstracts of Papers of the American Chemical Society. 2004, MAR 28; 227(031-MEDI, Part 2): U10-U10.
  1. 23.   Conformationally constrained diacylglycerol (DAG) analogs: 4-C-hydroxyethyl-5-O-acyl-2,3-dideoxy-D-glyceropentono-1,4-lactone analogs as protein kinase C (PKC) ligands
  2. Lee, J.; Kim, S. Y.; Kang, J. H.; Acs, G.; Acs, P.; Blumberg, P. M.; Marquez, V. E.
  3. European Journal of Medicinal Chemistry. 2004 39(1): 69-77.
  1. 24.   Antineoplastic agents 491. Synthetic conversion of aaptamine to isoaaptamine, 9-demethylaaptamine, and 4-methylaaptamine
  2. Pettit, G. R.; Hoffmann, H.; Herald, D. L.; McNulty, J.; Murphy, A.; Higgs, K. C.; Hamel, E.; Lewin, N. E.; Pearce, L. V.; Blumberg, P. M.; Pettit, R. K.; Knight, J. C.
  3. Journal of Organic Chemistry. 2004 69(7): 2251-2256.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel